The Future of Cancer care

OARC-X1 VENTURE

Project: Adaptive Oncotripsy & Systemic Regeneration Protocol

Date: March 2026

Status: Pre-Clinical Validation Phase

Target: Stage III/IV Solid Tumor Lysis & Cachexia Reversal

1. THE CHALLENGE: The "Static Tissue" Barrier

Traditional non-invasive therapies (HIFU/Lithotripsy) suffer from two fatal flaws:

1. Acoustic Shadowing: Bone and dense fascia block sound waves, leaving "cold spots" where malignant cells survive.

2. Gastric Distress: High-intensity vibration often causes nausea, forcing clinicians to lower power levels, thereby reducing efficacy.

2. THE SOLUTION: The OARC Integrated Ecosystem

We developed a closed-loop environment that synchronizes chaotic physics with targeted biochemistry.

A. The Mechanical Layer (OAGA)

Using our proprietary C-engine, we have created the future of cancer care